Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
InflaRx N.V | IFRX | Aug 30, 2024 | 1.59 | -4.22 |
Inflection Point Acquisition II | IPXX | Aug 30, 2024 | 10.67 | 0.00 |
Inflection Point Acquisition II Unit | IPXXU | Aug 30, 2024 | 10.75 | -0.19 |
Infobird | IFBD | Aug 30, 2024 | 1.75 | -0.52 |
Informatica | INFA | Aug 30, 2024 | 24.91 | -0.80 |
Information Services Group | III | Aug 30, 2024 | 3.50 | +0.86 |
Information Technology ETF Vanguard | VGT | Aug 30, 2024 | 573.97 | +1.04 |
Infosys ADR | INFY | Aug 30, 2024 | 23.28 | +0.34 |
InfuSystems | INFU | Aug 30, 2024 | 6.65 | +2.78 |
ING Group ADR | ING | Aug 30, 2024 | 18.21 | +0.50 |
Ingersoll Rand | IR | Aug 30, 2024 | 91.45 | +0.72 |
Ingevity | NGVT | Aug 30, 2024 | 39.53 | +0.15 |
Ingles Markets A | IMKTA | Aug 30, 2024 | 74.00 | +0.68 |
Ingredion | INGR | Aug 30, 2024 | 134.31 | +0.58 |
Inhibikase Therapeutics | IKT | Aug 30, 2024 | 1.40 | +0.97 |
Inhibrx Biosciences | INBX | Aug 30, 2024 | 14.56 | +4.67 |
InMed | INM | Aug 30, 2024 | 0.35 | +2.93 |
InMode | INMD | Aug 30, 2024 | 16.71 | +4.44 |
INmune Bio | INMB | Aug 30, 2024 | 6.62 | -3.50 |
Innate Pharma ADR | IPHA | Aug 30, 2024 | 2.29 | -5.94 |
Inno Holdings | INHD | Aug 30, 2024 | 0.46 | +3.84 |
Innodata | INOD | Aug 30, 2024 | 17.28 | +0.58 |
Innospec | IOSP | Aug 30, 2024 | 115.26 | +1.17 |
InnovAge | INNV | Aug 30, 2024 | 6.36 | +1.27 |
Innovate | VATE | Aug 30, 2024 | 4.14 | +0.24 |
Innovative Eyewear | LUCY | Aug 30, 2024 | 5.03 | -1.18 |
Innovative Industrial Properties | IIPR | Aug 30, 2024 | 124.28 | +0.45 |
Innovative Industrial Properties A Pref | IIPR-A | Aug 30, 2024 | 25.57 | -0.12 |
Innovative Solutions and Support | ISSC | Aug 30, 2024 | 7.02 | +0.29 |
Innovid | CTV | Aug 30, 2024 | 1.83 | +1.11 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.